These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4355034)

  • 1. Expression of tumor-specific antigens in mouse somatic cell hybrids.
    Jami J; Ritz E
    Cancer Res; 1973 Oct; 33(10):2524-8. PubMed ID: 4355034
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera.
    Yokochi T; Kawashima K; Nakashima I; Nagase F; Isobe K; Nagura E; Yamada K; Miyadai T; Kimura Y
    Cancer Res; 1987 Feb; 47(4):1006-9. PubMed ID: 3542198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H
    Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
    Fuji H; Murakami M
    J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenicity and immunogenicity of somatic cell hybrids between L1210 mouse leukemia cell and L-fibroblast.
    Watanabe E; Kawashima K; Isobe K; Yamada K; Saga S; Takahashi T
    Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):121-9. PubMed ID: 6858561
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell surface antigens of L-1210 leukemia recognized by monoclonal antibodies.
    Szkudlarek J; Steuden I; Salwa J; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1984; 32(6):671-5. PubMed ID: 6536238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. II. Increased expression of tumor-associated antigens on subline cells recognized by serologic and transplantation methods.
    Fuji H; Mihich E; Pressman D
    J Natl Cancer Inst; 1979 Jun; 62(6):1503-10. PubMed ID: 286122
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in the immunogenicity of leukemia L1210 sublines in DBA-2 mice.
    Mihich E; Kitano M
    Cancer Res; 1971 Dec; 31(12):1999-2003. PubMed ID: 5120297
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic differences between leukemia L1210 and a subline resistant to methylglyoxal-bis(guanylhydrazone).
    Kitano M; Mihich E; Pressman D
    Cancer Res; 1972 Feb; 32(2):181-6. PubMed ID: 5061638
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonmalignancy of hybrids derived from two mouse malignant cells. I. Hybrids between L1210 leukemia cells and malignant L cells.
    Jami J; Ritz E
    J Natl Cancer Inst; 1973 Nov; 51(5):1647-53. PubMed ID: 4762938
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of tumor resistance in mice by L1210 leukemia cells persistently infected with HVJ (Sendai virus).
    Takeyama H; Kawashima K; Yamada K; Ito Y
    Gan; 1979 Aug; 70(4):493-501. PubMed ID: 229053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of antibodies against ML antigen in the xenogeneic host.
    Radzikowski C; Zak-Nejmark T; Wysocka M; Steuden J
    Arch Immunol Ther Exp (Warsz); 1977; 25(4):507-13. PubMed ID: 931552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential localization of H-2 and teratoma-defined antigens on mouse L cell fibroblasts.
    Ostrand-Rosenberg S; Edidin M; Wetzel B
    Scan Electron Microsc; 1979; (3):595-600, 548. PubMed ID: 524026
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential expression of murine leukemia antigen on L1210 parental and drug-resistant sublines.
    Strzadala L; Opolski A; Radzikowski C; Mihich E
    Cancer Res; 1981 Dec; 41(12 Pt 1):4934-7. PubMed ID: 7306993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sendai produced somatic cell hybrids between L cell strains and between liver and L cells.
    Coon HG; Weiss MC
    Wistar Inst Symp Monogr; 1969; 9():83-96. PubMed ID: 4335392
    [No Abstract]   [Full Text] [Related]  

  • 17. A significant role of proximity of HVJ-antigen in the generation of tumor immunity.
    Kawashima K; Watanabe E; Kato Y; Suzuki H; Minami S; Isobe K; Ogura M; Nagura E; Yamada K
    Gan; 1981 Dec; 72(6):955-8. PubMed ID: 6281118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increase in the sensitivity of leukemia cells, incubated in interferon, to the effect of immune serum].
    Skurkovich SV; Kalinina IA; Eremkina EI; Bulycheva TI
    Biull Eksp Biol Med; 1976 Dec; 82(12):1459-61. PubMed ID: 1023976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunity after treatment of Ehrlich tumor with diphtheria toxin.
    Buzzi S; Buzzi L
    Cancer Res; 1974 Dec; 34(12):3481-6. PubMed ID: 4429964
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigenic tumor cell variants obtained with mutagens.
    Boon T
    Adv Cancer Res; 1983; 39():121-51. PubMed ID: 6353885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.